Skip to content
Open access

Association Between Vitamin D Status, Regulatory T Cells, and Disease Severity in Pediatric Systemic Lupus Erythematosus

Aug 2026 · Turkish Journal of Immunology · 0 citations

Abstract

Objective: Systemic lupus erythematosus (SLE) is characterized by loss of immune tolerance that is often associated with regulatory T (Treg) cell dysfunction. Vitamin D is known to enhance Treg differentiation and expansion. This study aimed to investigate the associations between serum vitamin D and zinc levels, Th17 and Treg cell percentages, and disease activity in pediatric patients with SLE. Materials and Methods: A cross-sectional study was conducted among children aged 7.5–18.9 years who were diagnosed with SLE at Dr. Saiful Anwar Hospital, Malang, Indonesia. Serum 25-hydroxyvitamin D [25(OH)D] levels were measured using an enzyme-linked immunosorbent assay (ELISA). Treg cell percentages were determined via flow cytometry. Disease activity was assessed using the Systemic Lupus Erythematosus Disease Activity Index (SLEDAI) score. Results: The study included 32 pediatric patients with SLE. Among the study participants, 25.0% had sufficient vitamin D levels, whereas 75.0% had suboptimal vitamin D status, including 28.1% with vitamin D insufficiency and 46.9% with vitamin D deficiency. Moderate-to-severe disease activity (SLEDAI ≥7) was observed in 84.4% of the participants. A significant positive correlation was observed between serum 25(OH)D levels and Treg cell percentages (r=0.402, p=0.0225), indicating that higher vitamin D levels were associated with increased Treg cell percentages. Conclusion: Pediatric patients with SLE show a high prevalence of vitamin D deficiency and insufficiency. Adequate vitamin D status is associated with increased Treg cell percentages, suggesting a potential role for vitamin D in enhancing immune regulation and managing disease severity in pediatric SLE.

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.